复星医药1类新药获批临床,太龙药业控制权生变,ST中珠子公司合同纠纷案获重审,福安药业头孢托仑匹酯颗粒过评

谈医说药
Dec 01

福安药业:公司的全资子公司福安药业集团庆余堂制药有限公司的头孢托仑匹酯颗粒获批注册。头孢托仑匹酯颗粒适用于敏感菌引起的浅表性皮肤感染、深部皮肤感染等疾病。截止目前,该药品共有2家企业(含庆余堂)通过一致性评价或视同通过一致性评价。复宏汉霖:近日,公司自主研发的HLX37(重组人源化抗PD-L1与抗VEGF双特异性抗体注射液)在晚期/转移性实体瘤患者中的1期临床试验申请获得国家药品监督管理局批准。...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10